Factors associated with delayed entry into primary HIV medical care after HIV diagnosis

AIDS

Volumn 24, Issue 6, 2010, Pages 928-930

  Bamford, Laura P ^a   Ehrenkranz, Peter D ^b   Eberhart, Michael G ^c   Shpaner, Mark ^c   Brady, Kathleen A ^c  

^a DREXEL UNIVERSITY COLLEGE OF MEDICINE   (United States)

^b CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

^c PHILADELPHIA DEPARTMENT OF PUBLIC HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ADULT; ARTICLE; CD4 LYMPHOCYTE COUNT; CONTROLLED STUDY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INFECTION RISK; MAJOR CLINICAL STUDY; MALE; MALE HOMOSEXUAL; MEDICAL CARE; PRIORITY JOURNAL; VIRUS DIAGNOSIS; VIRUS LOAD; VIRUS TRANSMISSION; WESTERN BLOTTING;

ADOLESCENT; ADULT; BLOTTING, WESTERN; CD4 LYMPHOCYTE COUNT; FEMALE; HIV INFECTIONS; HUMANS; MALE; MIDDLE AGED; PHILADELPHIA; POPULATION SURVEILLANCE; RETROSPECTIVE STUDIES; RISK FACTORS; TIME FACTORS; VIRAL LOAD; YOUNG ADULT;

EID: 77949546303     PISSN: 02699370     EISSN: 14735571     Source Type: Journal    
DOI: 10.1097/QAD.0b013e328337b116     Document Type: Article

References (14)

1. Centers for Disease Control and Prevention. HIV Prevention Strategic Plan through 2005. Goal 3, Objective 5, January 2001 [cited 17 March 2006]. pp. 1-82.
2. Centers for Disease Control and Prevention. HIV/AIDS Surveillance Report, 2005. Rev ed. US Department of Health and Human Services; Atlanta. CDC 2007; 17: 1-54.
3. Palella FJ, Delaney KM, Moorman AC, Loveless MO, Fuhrer J, Satten GA, et al. Declining morbidity and mortality among patients with advanced human immunodeficiency virus infection. N Engl J Med 1998; 338:853-860.
4. Mocroft A, Ledergerber B, Katlama C, Kirk O, Reiss P, d'Arminio Monforte A, et al. Decline in the AIDS and death rates in the EuroSIDA study: an observational study. Lancet 2003; 362:22-29.
5. Sterne JA, Hernan MA, Ledergerber B, Tilling K, Weber R, Sendi P, et al. Long-term effectiveness of potent antiretroviral therapy in preventing AIDS and death: a prospective cohort study. Lancet 2005; 366:378-384.
6. Quinn TC, Wawer MJ, Sewankambo N, Serwadda D, Li C, Wabwire-Mangen F, et al. Viral load and heterosexual transmission of human immunodeficiency virus type 1. Rakai Project Study Group. N Engl J Med 2000; 342:921-929.
7. Kamb ML, Fishbein M, Douglas JM, Rhodes F, Rogers J, Bolan G, et al. Efficacy of risk-reduction counseling to prevent human immunodeficiency virus and sexually transmitted diseases: a randomized controlled trial. Project RESPECT Study Group. JAMA 1998; 280:1161-11677.
8. Rietmeijer CA, Kane MS, Simons PZ, Corby NH, Wolitski RJ, Higgins DL, et al. Increasing the use of bleach and condoms among injecting drug users in Denver: outcomes of a targeted, community-level HIV prevention program. AIDS 1996; 10: 291-298.
9. Hogg RS, YipB,Chan KJ, WoodE,Craib KJ, O'Shaughnessy MV, Montaner JS. Rates of disease progression by baseline CD4 cell count and viral load after initiating triple-drug therapy. JAMA 2001; 286:2568-3257.
10. Zolopa A,AndersenJ,PowderlyW,SanchezA,Sanne I,Suckow C, et al. Early antiretroviral therapy reduces AIDS progression/ death in individuals with acute opportunistic infections: a multicenter randomized strategy trial. PLoS One 2009; 4: e5575.
11. Krentz HB, Auld MC, Gill MJ. The high cost of medical care for patients who present late (CD4 <200 cells/microL) with HIV infection. HIV Med, 2004;5:93-98.
12. Samet JH, Freedburg KS, Stein MD, Lewis R, Savetsky J, Sullivan L, et al.Trillion virion delay: time from testing positive for HIV to presentation for primary care.Arch Intern Med1998;158:734-740.
13. Turner BJ, Cunningham WE, Duan N, Andersen RM, Shapiro MF, Bozzette SA, et al., for the HIV Cost and Services Utilization Study (HCSUS) Access Research Team Members. Delayed medical care after diagnosis in a US national probability sample of persons infected with human immunodeficiency virus. Arch Intern Med 2000; 160:2614-2622.
14. Torian LV, Wiewel EW, Liu K, Sackoff JE, Frieden TR. Risk factors for delayed initiation of medical care after diagnosis of human immunodeficiency virus. Arch Intern Med 2008; 168:1181-1187.